We are live on ! Find out more
BDSX icon

Biodesix
BDSX

41 hedge funds and large institutions have $21.4M invested in Biodesix in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 21 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

163% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 8

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.04% less ownership

Funds ownership: 0.79% → 0.75% (-0.04%)

2% less funds holding

Funds holding: 42 → 41 (-1)

14% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 7

39% less capital invested

Capital invested by funds: $34.9M → $21.4M (-$13.5M)

Holders
41
Holders Change
-1
Holders Change %
-2.38%
% of All Funds
0.63%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
21
Reduced
8
Closed
7
Calls
$68K
Puts
–
Net Calls
+$68K
Net Calls Change
+$66K

Top Buyers

1
BC
Birchview Capital
Vermont
+$965K
2
BCM
Bridgeway Capital Management
Texas
+$686K
3
Millennium Management
Millennium Management
New York
+$339K
4
Two Sigma Investments
Two Sigma Investments
New York
+$183K
5
CC
Chicago Capital
Illinois
+$176K

Top Sellers

1
OIM
Oracle Investment Management
Connecticut
-$1.49M
2
CCA
Conestoga Capital Advisors
Pennsylvania
-$946K
3
PGM
Parian Global Management
New York
-$786K
4
CAM
Connacht Asset Management
New York
-$741K
5
AWE
Avidian Wealth Enterprises
Texas
-$411K
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
1
Birchview Capital
Vermont
$6.63M +$965K +7,390 +13%
BlackRock
2
BlackRock
New York
$3.05M +$39.6K +303 +1%
PGM
3
Parian Global Management
New York
$2.1M -$786K -6,020 -23%
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.99M +$914 +7 +0%
CC
5
Cannell & Co
New York
$1.09M – – –
Geode Capital Management
6
Geode Capital Management
Massachusetts
$851K +$64.8K +496 +7%
State Street
7
State Street
Massachusetts
$724K +$4.57K +35 +0.5%
FAM
8
Fred Alger Management
New York
$710K -$32.4K -248 -4%
Northern Trust
9
Northern Trust
Illinois
$558K +$4.7K +36 +0.7%
BCM
10
Bridgeway Capital Management
Texas
$555K +$686K +5,250 New
Two Sigma Investments
11
Two Sigma Investments
New York
$355K +$183K +1,401 +72%
Morgan Stanley
12
Morgan Stanley
New York
$345K -$282K -2,161 -40%
Millennium Management
13
Millennium Management
New York
$275K +$339K +2,595 New
Citadel Advisors
14
Citadel Advisors
Florida
$261K -$2.48K -19 -0.8%
JP Morgan Chase
15
JP Morgan Chase
New York
$261K +$20.8K +159 +7%
William Blair & Company
16
William Blair & Company
Illinois
$217K -$1.44K -11 -0.5%
Two Sigma Advisers
17
Two Sigma Advisers
New York
$181K +$99.2K +760 +80%
Charles Schwab
18
Charles Schwab
California
$167K – – –
Bank of New York Mellon
19
Bank of New York Mellon
New York
$156K +$4.18K +32 +2%
CC
20
Chicago Capital
Illinois
$143K +$176K +1,348 New
D.E. Shaw & Co
21
D.E. Shaw & Co
New York
$115K +$36.2K +277 +34%
PP
22
PDT Partners
New York
$91K -$40.4K -309 -26%
N
23
Nuveen
North Carolina
$89K -$66.9K -512 -34%
Nomura Holdings
24
Nomura Holdings
Japan
$63K +$80.7K +618 New
New York State Common Retirement Fund
25
New York State Common Retirement Fund
New York
$56K – – –
1
2

BDSX Hedge Fund Activity: Q4 2021 in Review

41 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q4 2021, worth a combined $21.4M — down 39% from $34.9M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of BDSX and 6 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 21 added.

The largest buyer was Birchview Capital, adding an estimated $965K. The largest seller was Oracle Investment Management, exiting entirely with an estimated $1.49M sold.

  • 41 institutional investors held Biodesix (BDSX) as of Q4 2021, down from 42 in Q3 2021.
  • Funds reported $21.4M of Biodesix stock for Q4 2021, down 39% quarter-over-quarter.
  • 6 funds opened new Biodesix positions in Q4 2021 and 7 closed out, a net change of -1 holder.
  • The largest Biodesix buyer in Q4 2021 was Birchview Capital, an estimated $965K added.
  • The largest Biodesix seller in Q4 2021 was Oracle Investment Management, an estimated $1.49M sold.

Based on aggregated 13F filings for Q4 2021.